(Q33376879)

26 July 2017

title

Characterization of anticoagulant heparinoids by immunoprofiling (English)

1 reference

26 July 2017

1 reference

1 reference

Johan van der Vlag

6

0 references

author name string

Tessa J Wijnhoven

1

1 reference

26 July 2017

Els M van de Westerlo

2

1 reference

26 July 2017

Nicole C Smits

3

1 reference

26 July 2017

Joost F Lensen

4

1 reference

26 July 2017

Angelique L Rops

5

1 reference

26 July 2017

Jo H Berden

7

1 reference

26 July 2017

Lambert P van den Heuvel

8

1 reference

26 July 2017

Toin H van Kuppevelt

9

1 reference

26 July 2017

publication date

2 October 2007

1 reference

26 July 2017

published in

Glycoconjugate Journal

1 reference

26 July 2017

volume

25

1 reference

26 July 2017

issue

2

1 reference

26 July 2017

page(s)

177-185

1 reference

https://scigraph.springernature.com/pub.10.1007/s10719-007-9070-z

26 July 2017

exact match

0 references

cites work

Characterization of anti-heparan sulfate phage display antibodies AO4B08 and HS4E4.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

One year course of oral sulodexide in the management of diabetic nephropathy.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Generic low-molecular-weight heparins: some practical considerations

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

A synthetic antithrombin III binding pentasaccharide is now a drug! What comes next?

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Antitumor and antimetastatic effect of warfarin and heparins.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Fondaparinux: a new antithrombotic agent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Tinzaparin sodium: a low-molecular-weight heparin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Roles of heparan-sulphate glycosaminoglycans in cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Human single chain antibodies against heparin: selection, characterization, and effect on coagulation

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Anticoagulants in thrombosis and cancer: the missing link

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Tumor cell surface heparan sulfate as cryptic promoters or inhibitors of tumor growth and metastasis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Recent advances in the study of the biosynthesis and functions of sulfated glycosaminoglycans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Synthesis and sorting of proteoglycans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Allergy to protamine sulfate

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Structural features and bleeding activity of commercial low molecular weight heparins: neutralization by ATP and protamine.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Structural characterization of low molecular weight heparins

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Production and chemical processing of low molecular weight heparins.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

A single dose of dalteparin effectively prevents clotting during haemodialysis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

A strategy for rapid sequencing of heparan sulfate and heparin saccharides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Glycosaminoglycan sulodexide decreases albuminuria in diabetic patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Enzymatic degradation of glycosaminoglycans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Mode of interaction between platelet factor 4 and heparin

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Improved quantitation and discrimination of sulphated glycosaminoglycans by use of dimethylmethylene blue.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Orgaran in heparin-induced thrombocytopenia

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Aberrant heparan sulfate profile in the human diabetic kidney offers new clues for therapeutic glycomimetics

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Pharmacokinetic studies of dalteparin (Fragmin), enoxaparin (Clexane), and danaparoid sodium (Orgaran) in stable chronic hemodialysis patients

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Oral sulodexide reduces albuminuria in microalbuminuric and macroalbuminuric type 1 and type 2 diabetic patients: the Di.N.A.S. randomized trial

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

A pilot study of the effect of the glycosaminoglycan sulodexide on microalbuminuria in type I diabetic patients.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2234449

Guidelines on the use and monitoring of heparin

31 October 2018

1 reference

12 December 2020

Heparin-induced thrombocytopenia

1 reference

12 December 2020

Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels

1 reference

12 December 2020

Qualitative and quantitative studies of heparin and chondroitin sulfates in normal human plasma

1 reference

12 December 2020

Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus

1 reference

12 December 2020

Effect of sulphated glycosaminoglycans on albuminuria in patients with overt diabetic (type 1) nephropathy

1 reference

12 December 2020

Danaparoid sodium lowers proteinuria in diabetic nephropathy

1 reference

12 December 2020

Specific binding of the chemokine platelet factor 4 to heparan sulfate

1 reference

12 December 2020

Effect of glycosaminoglycans on urinary albumin excretion in insulin-dependent diabetic patients with micro- or macroalbuminuria

1 reference

12 December 2020

10.1007/S10719-007-9070-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

26 July 2017

0 references

1 reference

26 July 2017

1 reference